| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director | Exec. Vice President &CFO
3 companies
Foster Jonathan P. serves as a Chief Financial Officer at MBRX and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 7 buys and 0 sells. Those positions are worth an estimated $547K at current prices.
The biggest single holding is INFU (~$358K) as Chief Financial Officer. Net of sales, the recent Form 4 record there shows accumulation of 5,582 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | MBRX Moleculin Biotech, Inc. | Chief Financial Officer | Buy | 293,333 | $0.00 | - | +2,377% | - | - | |
| Jun 23, 2025 | MBRX Moleculin Biotech, Inc. | Chief Financial Officer | Buy | 270,270 | $0.37 | $99,999.90 | +1,561% | +49.0% | -59.8% | |
| Dec 26, 2023 | MBRX Moleculin Biotech, Inc. | Chief Financial Officer | Buy | 28,986 | $0.69 | $20,000.34 | +56.2% | -46.0% | -81.8% | |
| Apr 25, 2017 | MBRX Moleculin Biotech, Inc. | Exec. Vice President &CFO | Buy | 10,000 | $0.86 | $8,649.00 | New | - | - | |
| Aug 18, 2015 | INFU Infusystem Holdings, Inc | Chief Financial Officer | Buy | 1,000 | $2.92 | $2,920.00 | +3.6% | - | - | |
| Jun 15, 2015 | INFU Infusystem Holdings, Inc | Chief Financial Officer | Buy | 312 | $3.12 | $973.44 | New | - | - | |
| May 15, 2015 | INFU Infusystem Holdings, Inc | Chief Financial Officer | Buy | 4,270 | $3.07 | $13,108.90 | +23.3% | - | - |